Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

155.93
BATS BZX Real-Time Price
As of 11:32am ET
 +0.50 / +0.32%
Today’s Change
133.64
Today|||52-Week Range
184.21
+6.65%
Year-to-Date
Pfizer's Epogen Biosimilar Gets Positive FDA Committee Vote
10:18am / Zacks.com - Paid Partner Content
Amgen Evenity Approval Derailed on Cardiovascular Side Effect
May 22 / Zacks.com - Paid Partner Content
Hm Payson & Co Buys Amgen Inc, Adient PLC, iShares Russell 2000, Sells Johnson Contro...
May 25 / GuruFocus News - Paid Partner Content
UCB Stock Plunges After Trials Reveal Safety Risk in Amgen JV
May 22 / TheStreet.com - Paid Partner Content
Radius Health Osteoporosis Drug Positive in Phase III Study
May 25 / Zacks.com - Paid Partner Content
Amgen Osteoporosis Drug Approval Plan Derailed Over Heart Safety Risk -- Jim Cramer W...
May 21 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Regeneron, Amgen and Celgene
May 25 / Zacks.com - Paid Partner Content
Independent Advisor Alliance Buys Vanguard Total Stock Market, iShares Core U.S. ...
May 19 / GuruFocus News - Paid Partner Content
Third Avenue Continues to Buy Amgen, 8 Others
May 24 / GuruFocus News - Paid Partner Content
Merck's (MRK) Keytruda Gets FDA Nod for Two New Indications
May 19 / Zacks.com - Paid Partner Content
Merck's (MRK) Keytruda Gets FDA Nod for Solid Tumor Cancers
May 24 / Zacks.com - Paid Partner Content
Amgen (AMGN) Submits BLA to FDA for Migraine Drug Erenumab
May 19 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: FDA Nod for Regeneron RA Drug, Amgen Hit by Study Data
May 24 / Zacks.com - Paid Partner Content
AbbVie Down on Humira Patent Loss: Is More Damage in Store?
May 18 / Zacks.com - Paid Partner Content
Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna
May 23 / GuruFocus News - Paid Partner Content
Celgene's (CELG) Revlimid Looks Solid on Label Expansion
May 16 / Zacks.com - Paid Partner Content
Astrazeneca (AZN) Gets Positive CHMP Opinion for Brodalumab
May 22 / Zacks.com - Paid Partner Content
Lilly's Migraine Drug Phase III Trials Meet Primary Endpoint
May 15 / Zacks.com - Paid Partner Content
Osteoporosis Drug Meets Primary and Secondary Endpoints
May 22 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: J.C. Penney, Amazon, Verizon, Citigroup and Amgen
May 15 / Zacks.com - Paid Partner Content
Safety risk for Amgen and UCB's bone drug lifts rival Radius
May 22 / FT.com - Paid Partner Content
Stock Market Today & Weak Retail Earnings
May 12 / Zacks.com - Paid Partner Content
Biotech Movers: Radius Health, Amgen, Paratek
May 22 / TheStreet.com - Paid Partner Content
Trump's tax plan; Boeing in focus; Earnings deluge
Apr 26 / CNNMoney.com